ThinkPatternGet the app
Story
BUSINESS · NOV 19, 2026

Sanofi Considers Acquisition of US Drugmaker Insmed

Sanofi is consulting with advisers regarding a potential acquisition of Insmed, causing the US drugmaker's shares to rise 14 percent.

Sanofi is weighing the acquisition of the U.S. drugmaker Insmed, according to a report from Bloomberg News. The French pharmaceutical company is currently consulting with advisers to study the potential deal, though deliberations remain ongoing and a final agreement may be weeks away.

Shares of Insmed rose 14 percent following the report, bringing the company's market valuation to $26.28 billion. Sanofi has declined to comment on the matter, stating it does not respond to market rumors, and Insmed has not yet provided a comment.


Reported across 5 outlets
Actors
SanofiInsmed

Keep reading in the app

The full story and every source, free in the app.